In other experimental conditions, PGJ2 reduced the expression of MMP-9 and breast cancer MCF-7 cell invasiveness [53], IL-6 production and neutrophil recruitment in gout arthritis [54], and mast cell infiltration in atopic dermatitis [5]. The gene discussed is IL6; the disease is atopic eczema.